One of the most recent studies out of Greece involved researchers looking into a vaporized weed formula with 13% CBD and 9% THC, and its effects on 69 patients with multiple sclerosis. The participants had varying symptoms, including muscle spasticity, bladder dysfunction, and disability progressions, all of which were analyzed at baseline levels to be evaluated again at three then six months. According to the researchers, “Significant improvement was observed across all outcome assessments,” after the patients were given vaporized weed.
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…